Early research (Phase 1)Study completedNCT03562494What this trial is testingVY-AADC02 for Parkinson's Disease With Motor Fluctuations (RESTORE-1)Who this might be right forParkinson's Disease Neurocrine Biosciences 14
Large-scale testing (Phase 3)Active Not RecruitingNCT02339064What this trial is testingInfusion of Apomorphine: Long-term Safety StudyWho this might be right forIdiopathic Parkinson's Disease MDD US Operations, LLC a subsidiary of Supernus Pharmaceuticals 99
Post-approval studies (Phase 4)Study completedNCT00307450What this trial is testingEfficacy and Safety of Levetiracetam Versus Placebo on Levodopa-induced Dyskinesias in Advanced Parkinson's DiseaseWho this might be right forParkinson's Disease Technische Universität Dresden 34
Testing effectiveness (Phase 2)Study completedNCT02641054What this trial is testingEfficacy Phase IIa Study of CVXL-0107 in Advanced Parkinson's DiseaseWho this might be right forIdiopathic Parkinson Disease CleveXel Pharma 21
Testing effectiveness (Phase 2)Looking for participantsNCT07102342What this trial is testingThis Clinical Trial is Designed to Evaluate the Safety, Tolerability, Feasibility and Preliminary Efficacy of NouvNeu001 (Human Dopaminergic Progenitor Cells Injection) in Patients With Parkinson's Disease.Who this might be right forParkinson Disease iRegene Therapeutics Co., Ltd. 5
Testing effectiveness (Phase 2)Study completedNCT00438607What this trial is testingDose-Finding Safety Study of BIIB014 in Combination With Levodopa in Moderate to Late Stage Parkinson's DiseaseWho this might be right forParkinson's Disease Biogen 83
Large-scale testing (Phase 3)Study completedNCT01286935What this trial is testing18-month Study of Long-term Efficacy & Safety of Safinamide as add-on Therapy in Patients With Mid-late Stage PDWho this might be right forParkinson's Disease Newron Pharmaceuticals SPA 544
Large-scale testing (Phase 3)Study completedNCT00244387What this trial is testingRotigotine Patch in Subjects With Advanced Stage, Idiopathic Parkinson's Disease Who Are Not Well Controlled on LevodopaWho this might be right forParkinson Disease, Idiopathic UCB Pharma 506
Testing effectiveness (Phase 2)Study completedNCT00296192What this trial is testingEfficacy, Safety and Tolerability of Rotigotine Nasal Spray for the Acute Treatment of Parkinson SymptomsWho this might be right forParkinson's Disease UCB Pharma 82
Testing effectiveness (Phase 2)Study completedNCT01515410What this trial is testingStudy in Advanced Parkinson's Disease Patients With Predictable Motor FluctuationsWho this might be right forParkinson's DiseaseMotor Fluctuations Depomed 34
Large-scale testing (Phase 3)Study completedNCT00142545What this trial is testingLong Term Safety and Efficacy of SC Apomorphine in Treatment of "Off" Episodes in Late-Stage Parkinson's DiseaseWho this might be right forParkinson Disease Mylan Bertek Pharmaceuticals 800
Not applicableLooking for participantsNCT06916507What this trial is testingStudy to Assess Real Life Effectiveness of Foslevodopa/Foscarbidopa in Adult German Participants at Initial Stages of Advanced Parkinson's Disease (EARLY-FOS)Who this might be right forParkinson's Disease AbbVie 125
Early research (Phase 1)Study completedNCT04630860What this trial is testingEvaluate the Pharmacokinetics and Safety of LY03003 in Patients With Advanced-stage PDWho this might be right forParkinson Disease Luye Pharma Group Ltd. 30
Post-approval studies (Phase 4)Study completedNCT01711866What this trial is testingA Phase 4, Open-label Study to Assess the Feasibility and Efficacy on Motor and Non-motor Symptoms of Switching From Pramipexole or Ropinirole to Rotigotine Transdermal Patch in Subjects With Advanced Idiopathic Parkinson's DiseaseWho this might be right forAdvanced Idiopathic Parkinson's Disease UCB BIOSCIENCES GmbH 87
Large-scale testing (Phase 3)Study completedNCT00134251What this trial is testingAscending Dose Tolerability/Safety of SLV308 for the Treatment of Parkinson's DiseaseWho this might be right forParkinson's Disease Solvay Pharmaceuticals
Large-scale testing (Phase 3)Study completedNCT00406588What this trial is testingSLV308 for Treatment of Patients With Parkinson's Disease Experiencing Motor FluctuationsWho this might be right forAdvanced Stage Parkinson's Disease Solvay Pharmaceuticals 295
Early research (Phase 1)Study completedNCT01621581What this trial is testingAAV2-GDNF for Advanced Parkinson s DiseaseWho this might be right forParkinson's Disease National Institute of Neurological Disorders and Stroke (NINDS) 25
Testing effectiveness (Phase 2)Study completedNCT02763137What this trial is testingIntermittent Oral Administration vs. Semi-continuous Intra-oral Administration of Levodopa/Carbidopa in Fluctuating Parkinsonian PatientsWho this might be right forParkinson Disease IRCCS San Raffaele Roma 18
Very early researchLooking for participantsNCT07100171What this trial is testingEvaluation of GM101 Injection in Patients With Parkinson's DiseaseWho this might be right forParkinson's Disease Genemagic Biosciences Co., Ltd 10
Large-scale testing (Phase 3)Study completedNCT01187966What this trial is testingEfficacy and Safety of Safinamide (50 and 100mg/Day) Versus Placebo, in Patients With Mid-late Stage Parkinson's DiseaseWho this might be right forParkinson's Disease Newron Pharmaceuticals SPA 669